News | October 16, 2024
Lupin launches Aptivate Achi Bhookh Fest in Mumbai and Suburbs
The first phase of the Aptivate Achi Bhookh Fest reached over 8,200 households
The first phase of the Aptivate Achi Bhookh Fest reached over 8,200 households
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
Akums Drugs will undertake this development and commercialization in India
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
Indoco is comprehensively working on the remedial action plan
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
This product is categorized as antacids, antiflatulents and anti-Ulcerants
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
